CORC  > 大连理工大学
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
Hou, Zhi-Jie; Luo, Xi; Zhang, Wei; Peng, Fei; Cui, Bai; Wu, Si-Jin; Zheng, Fei-Meng; Xu, Jie; Xu, Ling-Zhi; Long, Zi-Jie
刊名ONCOTARGET
2015
卷号6页码:6326-6340
关键词flubendazole breast cancer cancer stem-like cell cell cycle tubulin
ISSN号1949-2553
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4406145
专题大连理工大学
作者单位1.Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China.,Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.
2.Dalian Univ Technol, Ctr Mol Med, Sch Life Sci & Biotechnol, Dalian, Peoples R China.
3.Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China.
4.Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Peoples R China.
5.Dalian Med Univ, Dept Crit Care Med, Affiliated Hosp 1, Dalian, Peoples R China.
推荐引用方式
GB/T 7714
Hou, Zhi-Jie,Luo, Xi,Zhang, Wei,et al. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells[J]. ONCOTARGET,2015,6:6326-6340.
APA Hou, Zhi-Jie.,Luo, Xi.,Zhang, Wei.,Peng, Fei.,Cui, Bai.,...&Liu, Quentin.(2015).Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.ONCOTARGET,6,6326-6340.
MLA Hou, Zhi-Jie,et al."Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells".ONCOTARGET 6(2015):6326-6340.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace